Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease, Secondary (chemically induced) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease, Secondary < Parkinson Disease, Secondary (chemically induced) < Parkinson Disease, Secondary (classification)  Facettes :

List of bibliographic references indexed by Parkinson Disease, Secondary (chemically induced)

Number of relevant bibliographic references: 98.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000428 (2014) Roberto Cilia [Italie] ; Giorgio Marotta ; Alice Belletti ; Chiara Siri ; Gianni PezzoliReversible dopamine transporter reduction in drug-induced Parkinsonism.
000885 (2013) Maryka Quik ; Archana Mallela ; Jason Ly ; Danhui ZhangNicotine reduces established L-dopa-induced dyskinesias in a monkey model of Parkinson’s disease
000A15 (2013) Jovana Lubarda [Canada] ; Sarah E. Groleau ; Nancy Thomas ; Mark A. Ferro ; Ram K. Mishra ; Joseph P. GabrieleDysregulation of novel catecholamine-regulated protein 40 (CRP40) in Parkinson's disease patients.
000D35 (2012) Philipp Mahlknecht ; Heike Stockner ; Stefan Kiechl ; Johann Willeit ; Verena Rastner ; Arno Gasperi ; Gregor Rungger ; Werner Poewe [Autriche] ; Klaus SeppiIs transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease?
001050 (2012) Maryka Quik [États-Unis] ; Xiomara A. Perez [États-Unis] ; Tanuja Bordia [États-Unis]Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease
001110 (2012) Samuel M. Goldman [États-Unis] ; Freya Kamel [États-Unis] ; G. Webster Ross [États-Unis] ; Grace S. Bhudhikanok [États-Unis] ; Jane A. Hoppin [États-Unis] ; Monica Korell [États-Unis] ; Connie Marras [Canada] ; Cheryl Meng [États-Unis] ; David M. Umbach [États-Unis] ; Meike Kasten [Allemagne] ; Anabel R. Chade [Argentine] ; Kathleen Comyns [États-Unis] ; Marie B. Richards [États-Unis] ; Dale P. Sandler [États-Unis] ; Aaron Blair [États-Unis] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis]Genetic Modification of the Association of Paraquat and Parkinson's Disease
001688 (2011) Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
001C97 (2010) Marta G. Vu Ckovi [États-Unis] ; Quanzheng Li [États-Unis] ; Beth Fisher [États-Unis] ; Angelo Nacca [États-Unis] ; Richard M. Leahy [États-Unis] ; John P. Walsh [États-Unis] ; Jogesh Mukherjee [États-Unis] ; Celia Williams [États-Unis] ; Michael W. Jakowec [États-Unis] ; Giselle M. Petzinger [États-Unis]Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride
002848 (2008) Christine D. Esper [Géorgie (pays)] ; Stewart A. Factor [Géorgie (pays)]Failure of recognition of drug‐induced parkinsonism in the elderly
003202 (2006) Annu Aggarwal [Inde] ; Sachin Vaidya [Inde] ; Samir Shah [Inde] ; Joshita Singh [Inde] ; Shrinivas Desai [Inde] ; Mohit Bhatt [Inde]Reversible Parkinsonism and T1W pallidal hyperintensities in acute liver failure
003421 (2006) Dominique Caparros-Lefebvre [France] ; John Steele [États-Unis] ; Yaichiro Kotake [Japon] ; Shigeru Ohta [Japon]Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: Possible synergy of neurotoxins
003D31 (2004) Lisa Jerome [États-Unis] ; Rick Doblin [États-Unis] ; Michael Mithoefer [États-Unis]Ecstasy use–Parkinson's disease link tenuous
003E89 (2003) Stephen J. Kish [Canada]What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
004139 (2003) Eduardo Tolosa [Espagne] ; Miguel Coelho [Espagne] ; Marisol Gallardo [Espagne]DAT imaging in drug‐induced and psychogenic parkinsonism
004374 (2002) Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France]Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence
004498 (2002) Y. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; C. Yoo [Corée du Sud] ; C. R. Lee [Corée du Sud] ; J. H. Lee [Corée du Sud] ; H. K. Kim [Corée du Sud] ; S. O. Yang [Corée du Sud] ; H. K. Chung [Corée du Sud] ; D. S. Lee [Corée du Sud] ; B. Jeon [Corée du Sud]Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean?
004534 (2002) Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis]Clozapine withdrawal symptoms in a Parkinson's disease patient
004544 (2002) Joanne E. Nash [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat
004693 (2001) Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain
004730 (2001) Egberto R. Barbosa [Brésil] ; Maria D. Leiros Da Costa [Brésil] ; Luiz A. Bacheschi [Brésil] ; Milberto Scaff [Brésil] ; Claudia C. Leite [Brésil]Parkinsonism after glycine‐derivate exposure
004845 (2001) Krishna P. Datla [Royaume-Uni] ; Stavia B. Blunt [Royaume-Uni] ; David T. Dexter [Royaume-Uni]Chronic L‐DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6‐OHDA or FeCl3 nigrostriatal lesions

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease, Secondary (chemically induced)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (chemically induced)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (chemically induced)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024